NRAS c.33A>G ;(p.A11=)

Variant ID: 1-115258749-T-C

NM_002524.4(NRAS):c.33A>G;(p.A11=)

This variant was identified in 6 publications

View GRCh38 version.




Publications:


NOX4 has the potential to be a biomarker associated with colon cancer ferroptosis and immune infiltration based on bioinformatics analysis.

Frontiers In Oncology
Yang, Xiaoping X; Yu, Yi Y; Wang, Zirui Z; Wu, Pingfan P; Su, Xiaolu X; Wu, Zhiping Z; Gan, Jianxin J; Zhang, Dekui D
Publication Date: 2022

Variant appearance in text: NRAS: A11a
PubMed Link: 36249057
Variant Present in the following documents:
  • DataSheet_1.pdf
View BVdb publication page



Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma.

Aging
Yang, Xin X; Mei, Minhui M; Yang, Jingze J; Guo, Jinlu J; Du, Fan F; Liu, Shi S
Publication Date: 2022-05-12

Variant appearance in text: NRAS: A11A
PubMed Link: 35550563
Variant Present in the following documents:
  • aging-14-204073-s001.xlsx, sheet 1
View BVdb publication page



Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma.

Frontiers In Oncology
Zhu, Zhipeng Z; Song, Mengyu M; Li, Wenhao W; Li, Mengying M; Chen, Sihan S; Chen, Bo B
Publication Date: 2021

Variant appearance in text: NRAS: A11A
PubMed Link: 34616672
Variant Present in the following documents:
  • DataSheet_1.xlsx, sheet 1
View BVdb publication page



Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Publication Date: 2018

Variant appearance in text: NRAS: A11A
PubMed Link: 29698444
Variant Present in the following documents:
  • pone.0196434.s001.xlsx, sheet 1
View BVdb publication page



A novel signalling screen demonstrates that CALR mutations activate essential MAPK signalling and facilitate megakaryocyte differentiation.

Leukemia
Kollmann, K K; Warsch, W W; Gonzalez-Arias, C C; Nice, F L FL; Avezov, E E; Milburn, J J; Li, J J; Dimitropoulou, D D; Biddie, S S; Wang, M M; Poynton, E E; Colzani, M M; Tijssen, M R MR; Anand, S S; McDermott, U U; Huntly, B B; Green, T T
Publication Date: 2017-04

Variant appearance in text: NRAS: A11A
PubMed Link: 27740635
Variant Present in the following documents:
  • Main text
View BVdb publication page



Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study.

Ebiomedicine
Yoshino, Takayuki T; Muro, Kei K; Yamaguchi, Kensei K; Nishina, Tomohiro T; Denda, Tadamichi T; Kudo, Toshihiro T; Okamoto, Wataru W; Taniguchi, Hiroya H; Akagi, Kiwamu K; Kajiwara, Takeshi T; Hironaka, Shuichi S; Satoh, Taroh T
Publication Date: 2015-04

Variant appearance in text: NRAS: A11A
PubMed Link: 26137573
Variant Present in the following documents:
  • main.pdf
View BVdb publication page